CA Patent

CA3116942A1 — Sublingual films comprising apomorphine and an organic base

Assigned to Sumitomo Pharma America Inc · Expires 2012-06-21 · 14y expired

What this patent protects

The invention features sublingual film fomiulations comprising apomorphine hydrochloride and pyridoxine, and methods of treating Parkinson's disease and restless leg syndrome.

USPTO Abstract

The invention features sublingual film fomiulations comprising apomorphine hydrochloride and pyridoxine, and methods of treating Parkinson's disease and restless leg syndrome.

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA3116942A1
Jurisdiction: CA
Classification: —
Expires: 2012-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma America Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.